PUBLISHER: Lucintel | PRODUCT CODE: 1263906
PUBLISHER: Lucintel | PRODUCT CODE: 1263906
Single Use Bioreactor Market Trends and Forecast
The future of the global single use bioreactor market looks promising with opportunities in pharmaceutical & biopharmaceutical companies, CROs & CMOs, and academic & research institutes. The global single use bioreactor market is expected to reach an estimated $11.1 billion by 2028 with a CAGR of 18.6% from 2023 to 2028. The major drivers for this market are expanding usage of single-use systems in the pharmaceutical and mammalian cell culture application and increasing demand for biologic and biosimilar drugs.
Single Use Bioreactor Market by Product, Type, Type of Cell, Molecule, Application, and End Use
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Single Use Bioreactor Market by Segments
Single Use Bioreactor Market by Segment
Single Use Bioreactor Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
Single-Use Bioreactor Systems
Up to 10L
11-100L
101-500L
501-1500L
Above 1500L
Single-Use Media Bags
2D Bags
3D Bags
Others
Single-Use Filtration Assemblies
Others
Single Use Bioreactor Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:
Stirred-Tanks
Wave-Induced
Bubble-Column
Others
Single Use Bioreactor Market by Type of Cell [Value ($B) Shipment Analysis from 2017 to 2028]:
Mammalian Cells
Bacterial Cells
Yeast Cells
Others
Single Use Bioreactor Market by Module Type [Value ($B) Shipment Analysis from 2017 to 2028]:
Monoclonal Antibodies
Vaccines
Gene Modified Cells
Stem Cells
Others
Single Use Bioreactor Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:
Research and Development
Process Development
Bioproduction
Single Use Bioreactor Market by End Use [Value ($B) Shipment Analysis from 2017 to 2028]:
Pharmaceutical & Biopharmaceutical Companies
CROs & CMOs
Academic & Research Institutes
Single Use Bioreactor Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
North America
Europe
Asia Pacific
The Rest of the World
List of Single Use Bioreactor Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, single use bioreactor companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the single use bioreactor companies profiled in this report include-
Sartorius Stedim Biotech
Thermo Fisher
Danaher
Merck
Celltainer Biotech
Single Use Bioreactor Market Insights
Lucintel forecasts that stirred tanks will remain the largest segment over the forecast period due to its growing usage in the bioproduction process of aerobic microbial cell cultures owing to its improved fluid mixing and oxygen transfer capabilities.
Pharmaceutical and biopharmaceutical companies are expected to remain the end use segment with the highest growth due to rapidly growing demand for disposable technology in pharma and biopharma sector and increased government investment in biopharmaceutical research.
North America will remain the largest region due to the rapid growth in the requirement for drug discovery, prompted by escalating incidence of chronic diseases among population, and existence of drug manufacturing facilities in the region.
Features of the Single Use Bioreactor Market
Market Size Estimates: Single use bioreactor market size estimation in terms of value ($B)
Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
Segmentation Analysis: Single use bioreactor market size by various segments, such as product, type, type of cell, molecule type, application, end use, and region
Regional Analysis: Single use bioreactor market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
Growth Opportunities: Analysis on growth opportunities in different products, types, types of cell, molecule types, applications, end uses, and regions for the single use bioreactor market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape for the single use bioreactor market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the single use bioreactor market size?
Answer: The global single use bioreactor market is expected to reach an estimated $11.1 billion by 2028.
Q2. What is the growth forecast for single use bioreactor market?
Answer: The global single use bioreactor market is expected to grow with a CAGR of 18.6% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the single use bioreactor market?
Answer: The major drivers for this market are expanding usage of single-use systems in the pharmaceutical and mammalian cell culture application and increasing demand for biologic and biosimilar drugs.
Q4. What are the major segments for single use bioreactor market?
Answer: The future of the single use bioreactor market looks promising with opportunities in pharmaceutical & biopharmaceutical companies, CROs & CMOs, and academic & research institutes.
Q5. Who are the key single use bioreactor companies?
Answer: Some of the key single use bioreactor companies are as follows:
Sartorius Stedim Biotech
Thermo Fisher
Danaher
Merck
Celltainer Biotech
Q6. Which single use bioreactor segment will be the largest in future?
Answer: Lucintel forecasts that stirred tanks will remain the largest type segment over the forecast period due to their growing usage in the bioproduction process of aerobic microbial cell cultures owing to their improved fluid mixing and oxygen transfer capabilities.
Q7. In single use bioreactor market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to the rapid growth in the requirement for drug discovery, prompted by escalating incidence of chronic diseases among population, and existence of drug manufacturing facilities in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.